ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Healthcare Disparities in Rheumatology Poster (0594–0622)

Date: Sunday, November 7, 2021

Time: 8:30AM-10:30AM

Meeting: ACR Convergence 2021

8:30AM-10:30AM
Abstract Number: 0600
A Cohort Study of Retention in Ambulatory Lupus Care Among Medicare Patients with SLE-related Hospitalizations
8:30AM-10:30AM
Abstract Number: 0608
Adaptation of a Shared Decision-Making Tool for Early Rheumatoid Arthritis Treatment Decisions with Indigenous Patients
8:30AM-10:30AM
Abstract Number: 0611
Association of Area Deprivation Index and Practice Patterns of Medicare Part D Rheumatologists
8:30AM-10:30AM
Abstract Number: 0603
Barriers and Potential Solutions in the Recruitment and Retention of Older Patients in Clinical Trials – Lessons Learned from Six Large Multi-center Randomized Controlled Trials
8:30AM-10:30AM
Abstract Number: 0621
Case Series of IgG4-related Disease in African American Patients at Two Large Academic Centers
8:30AM-10:30AM
Abstract Number: 0609
Challenges of Caring for Patients with Inflammatory Arthritis Experiencing Homelessness: Preliminary (12- Month) Follow-up Observations and Identification of Certain Barriers to Care
8:30AM-10:30AM
Abstract Number: 0617
Concerns and Beliefs About COVID-19 Vaccination Among Racial and Ethnic Minority Patients with Rheumatic Disease
8:30AM-10:30AM
Abstract Number: 0598
Differences in Discoid Lupus Erythematosus Skin Lesion Distribution and Characteristics in Black and Non-Black Patients: A Retrospective Cohort Study
8:30AM-10:30AM
Abstract Number: 0604
Disparities in Burden of Disease in Patients with RA Across Racial and Ethnic Groups
8:30AM-10:30AM
Abstract Number: 0599
Effectiveness of a Provider Led Intervention on Medication Adherence in an Urban Lupus Clinic
8:30AM-10:30AM
Abstract Number: 0622
Ethnic Disparities in Giant-Cell Arteritis: A Clinical Comparison Among Caucasian and Hispanic Patients in the Inland Empire of Southern California
8:30AM-10:30AM
Abstract Number: 0610
Evaluating Patient No Show Rates to Rheumatology Appointments Across a Regional Healthcare System
8:30AM-10:30AM
Abstract Number: 0606
How Might We Care for Rheumatoid Arthritis (RA) Patients Unable to See a Rheumatologist And/or Use Certain of Our Medications? Proposed Preliminary Recommendations for RA Patients Who Don’t Meet Our Established Guidelines
8:30AM-10:30AM
Abstract Number: 0605
Impact of Area of Residence on Perceptions of Health and Disease Activity in Ethnic Minorities with Rheumatoid Arthritis in an Urban Setting
8:30AM-10:30AM
Abstract Number: 0620
Is There a Difference in Disease Activity Between Genders in Axial Spondyloarthritis? 6-year Longitudinal Data from a Large National Cohort
8:30AM-10:30AM
Abstract Number: 0595
Lupus Nephritis Disparities Amongst Hospitalizations in the United States: A National Inpatient Sample Study
8:30AM-10:30AM
Abstract Number: 0618
Post-acute Sequelae of SARS-CoV-2 and Serological Response in a Cohort of Patients with Rheumatic Diseases
8:30AM-10:30AM
Abstract Number: 0616
Race and Socioeconomic Status and COVID-19 Outcomes in Patients with Rheumatic Diseases: Findings from a Tertiary Care Center in the Deep South
8:30AM-10:30AM
Abstract Number: 0619
Racial and Ethnic Disparities in Pregnancy Outcomes Among Women with Rheumatic Diseases: A Systematic Literature Review and Quantitative Analysis
8:30AM-10:30AM
Abstract Number: 0601
Racial Differences in Medication Beliefs Among SLE Patients
8:30AM-10:30AM
Abstract Number: 0596
Racial Disparities in US Adults with Systemic Lupus Erythematosus: Prevalence, Quality of Life, Comorbidities and Healthcare Costs
8:30AM-10:30AM
Abstract Number: 0613
Racial/Ethnic Disparities in Prescription Medications in a Large Urban Medical Center
8:30AM-10:30AM
Abstract Number: 0612
Rheumatology Care for the Underserved in Central Texas
8:30AM-10:30AM
Abstract Number: 0614
Sex and Race Based Utilization of Healthcare for Ocular Inflammation and Infection: Comparing the Results from the Medicare and the IRIS Data
8:30AM-10:30AM
Abstract Number: 0597
Sex Differences in Multimorbidity Between Patients with Systemic Lupus Erythematosus and Comparators in a Large Nationwide US Study
8:30AM-10:30AM
Abstract Number: 0615
Socioeconomic Characteristics Associated with Electronic Health Care Utilization in an Urban Rheumatology Clinic During the COVID-19 Pandemic
8:30AM-10:30AM
Abstract Number: 0594
The Burden of Systemic Lupus in Five Distinct Racial and Ethnic Groups in Israel: A Population-based Study
8:30AM-10:30AM
Abstract Number: 0602
Use of a Popular Opinion Leader Model to Disseminate Information Virtually About Clinical Trial Enrollment to People of Color with Lupus
8:30AM-10:30AM
Abstract Number: 0607
Validation Studies of Rheumatoid Arthritis Patient-Reported Outcome Measures in Diverse Populations at Risk for Inequity: A Systematic Review

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology